Axcelis Technologies, Inc.

ACLS · NASDAQ

Axcelis has a focused ion-implant franchise, a sizable installed-base service layer, strong cash and investment liquidity, and Veeco optionality. The hard part is that power and mature-node digestion have pulled revenue down, backlog is lower, export controls matter, and the next leg needs memory strength to become orders instead of just commentary.

Follow Add to Watchlist Ask Question

NASDAQ ACLS Coverage Bootstrap Semiconductors Capital Equipment Ion Implantation

Latest ReportMay 13, 2026Axcelis: the implant specialist waiting for memory to rescue a power-chip hangoverView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.